View Larger Image CHMP positive opinions January 2021 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-25-29-january-2021 Omakase2021-02-02T13:20:04+00:00February 2nd, 2021|News & Events| Share This Article LinkedInEmail Related Posts Omakase has participated in a expert panel on “EU Joint HTA of Orphan Drugs and the Likely Local Implications” organised by World Orphan Drug Congress Europe in Sitges Omakase has participated in a expert panel on “EU Joint HTA of Orphan Drugs and the Likely Local Implications” organised by World Orphan Drug Congress Europe in Sitges November 24th, 2022 Omakase Consulting keeps growing with a new area of Institutional Relationships and Communication Omakase Consulting keeps growing with a new area of Institutional Relationships and Communication October 26th, 2022 Studio the economically justifiable price in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy Studio the economically justifiable price in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy September 13th, 2022 MCDA methodology in the Farmacia Hospitalaria journal MCDA methodology in the Farmacia Hospitalaria journal July 6th, 2022 Alicia Gil, CEO Omakase Consulting attended a session held in the Spanish National Congress organised by FEDER (Spanish Rare Diseases Organisation) Alicia Gil, CEO Omakase Consulting attended a session held in the Spanish National Congress organised by FEDER (Spanish Rare Diseases Organisation) June 29th, 2022 The new update in the information system BIFIMED from the Spanish Ministry of Health The new update in the information system BIFIMED from the Spanish Ministry of Health June 28th, 2022 Omakase Consulting keeps growing! Omakase Consulting keeps growing! June 22nd, 2022 The AEMPS, recognised with the 2021 Public Health Figure award granted by Fundamed & Wecare-u The AEMPS, recognised with the 2021 Public Health Figure award granted by Fundamed & Wecare-u July 9th, 2021 | 0 Comments
